Risk of COVID-19 Infection After Vaccination
NCT04848441 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000000
Last updated 2021-04-19
Summary
The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.
Conditions
- Vaccination; Infection
- Covid19
Interventions
- OTHER
-
The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1
The purpose of the study is to compare the effects of BNT162b2, mRNA-1273 and ChAdOx1 with respect to incident COVID-19 infection of different severities.
Sponsors & Collaborators
-
Umeå University
lead OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2021-08-01
- Completion
- 2021-08-01
More Related Trials
-
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
NCT05387655 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency
NCT04954469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BCG Vaccine for Health Care Workers as Defense Against COVID 19
NCT04348370 ·Status: COMPLETED ·Phase: PHASE4
-
BCG Vaccination to Prevent COVID-19
NCT04632537 ·Status: WITHDRAWN ·Phase: PHASE3
-
Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines
NCT04954651 ·Status: COMPLETED
-
Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults
NCT01829490 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
NCT04239313 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece
NCT04756817 ·Status: COMPLETED
-
Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?
NCT04347876 ·Status: UNKNOWN
-
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
NCT06062238 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers
NCT04384549 ·Status: UNKNOWN ·Phase: PHASE3
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults
NCT01879163 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route
NCT01497769 ·Status: COMPLETED ·Phase: PHASE1
-
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic
NCT04373291 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A
NCT01683773 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
NCT00395720 ·Status: COMPLETED ·Phase: PHASE1
-
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 ·Status: COMPLETED
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
NCT00427830 ·Status: COMPLETED ·Phase: PHASE1
-
Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau
NCT02953327 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV
NCT00731471 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines
NCT05507671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A
NCT01194180 ·Status: COMPLETED ·Phase: PHASE1
-
BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)
NCT04534803 ·Status: WITHDRAWN ·Phase: PHASE3